Potential considerations & concern in the risk characterization for the interaction profiles of metals

Indian Journal of Medical Research

Volumn 128, Issue 4, 2008, Pages 462-483

  Choudhury, Harlal ^a   Mudipalli, Anu ^b  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Hazard index; Reference dose (RfD); Target organ toxicity dose (TTD)

Indexed keywords

ARSENIC; CADMIUM; EDETIC ACID; ERYTHROCYTE ENZYME; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEAD; METALLOTHIONEIN; PORPHOBILINOGEN SYNTHASE; SUPEROXIDE DISMUTASE; ZINC; METAL;

BIOACCUMULATION; BLOOD PRESSURE; BLOOD TOXICITY; BONE DISEASE; CYTOTOXICITY; DIETARY INTAKE; ENVIRONMENTAL EXPOSURE; FEMALE FERTILITY; GASTROINTESTINAL ABSORPTION; HOMEOSTASIS; HUMAN; HYPERKERATOSIS; INHALATION; IRON ABSORPTION; KIDNEY CLEARANCE; LEAD POISONING; LIPID PEROXIDATION; LONG TERM EXPOSURE; METHYLATION; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; OCCUPATIONAL EXPOSURE; REVIEW; SKIN ABSORPTION; SKIN DEFECT; TESTIS DISEASE; TOXICOKINETICS; TOXICOLOGY; URINARY EXCRETION; ZINC DEFICIENCY; CHEMISTRY; MINING; RISK ASSESSMENT;

ENVIRONMENTAL EXPOSURE; HUMANS; METALS; MINING; OCCUPATIONAL EXPOSURE; RISK ASSESSMENT;

EID: 61849108647     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Review

References (140)

1. Saxena DK, Murthy RC, Singh C, Chandra SV. Zinc protects testicular injury induced by concurrent exposure to cadmium and lead in rats. Res Commun Chem Pathol Pharmacol 1989; 64: 317-29.
2. U.S. Environmental Protection Agency. Revised interim soil lead guidance for CERCLA sites and RCRA corrective action facilities. Report No.: OSWER Directive No. 9355.4-12. EPA/540/F-94/043. PB94-963282. Washington, DC: U.S. Environmental Protection Agency, Office of Emergency and Remedial Response; 1994.
3. U.S. Environmental Protection Agency. Technical support document: parameters and equations used in the integrated exposure uptake biokinetic model for lead in children (v. 0.99d). Report No.: EPA/ 540/R-94/040. PB94-963505. Washington, DC: U.S. Environmental Protection Agency, Office of Emergency and Remedial Response; 1994.
4. U.S. Environmental Protection Agency. Guidelines for the health risk assessment of chemical mixtures. Fed Regist 1986; 51: 34014-25.
5. U.S. Environmental Protection Agency. Risk assessment guidance for superfund. Vol. I. Human health evaluation manual, Part A, Interim Final. Report No.: EPA/540/1-89/002. OSWER 9285.7-02B. Washington, DC: U.S. Environmental Protection Agency, Office of Emergency and Remedial Response; 1989.
6. U.S. Environmental Protection Agency. Air quality criteria for lead. Report No.: EPA/600/8-83/028aF, bF, cF, dF. Research Triangle Park, NC: U.S. Environmental Protection Agency, Office of Research and Development, Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office; 1986.
7. Agency for Toxic Substances and Diseases Registry. Toxicological profile for zinc (Update). Report No.: TP-93/15. Atlanta, GA: U.S. Department of Health and Human Services; 1994.
8. Agency for Toxic Substances and Diseases Registry. Final report: Multisite lead and cadmium exposure study with biological markers incorporated. Atlanta, GA: U.S. Department of Health and Human Services; 1995. p. 1-10, 36-45.
9. Agency for Toxic Substances and Diseases Registry. Toxicological profile for cadmium (Update, Draft for Public Comment). Atlanta, GA: U.S. Department of Health and Human Services; 1997.
10. Agency for Toxic Substances and Diseases Registry. Toxicological profile for arsenic (Update, Draft for Public Comment). Atlanta, GA: U.S. Department of Health and Human Services; 1998.
11. Agency for Toxic Substances and Diseases Registry. Toxicological profile for lead (Update). Atlanta, GA: U.S. Department of Health and Human Services; 1999.
12. U.S. Environmental Protection Agency. Integrated Risk Information System (IRIS). IRIS assessment for arsenic (CASRN 7440-38-2). Washington, DC: Office of Research and Development, National Center for Environmental Assessment [updated 1998]. Available from: http://www.epa.gov/ncea/iris/subst/0278.htm, accessed in February 2008.
13. Yamanaka K, Hayashi H, Tachikawa M, Kato K, Hasegawa A, Oku N, et al. Metabolic methylation is a possible genotoxicity-enhancing process of inorganic arsenics. Mutat Res 1997; 394: 95-101.
14. Mass MJ, Tennant A, Roop BC, Cullen WR, Styblo M, Thomas DJ. Methylated trivalent arsenic species are genotoxic. Chem Res Toxicol 2001; 14: 355-61.
15. Nesnow S, Roop BC, Lambert G, Kadiiska M, Mason RP, Cullen WR, et al. DNA damage induced by methylated trivalent arsenicals is mediated by reactive oxygen species. Chem Res Toxicol 2002; 15: 1627-34.
16. Colognato R, Coppede F, Ponti J, Sabbioni E, Migliore L. Genotoxicity induced by arsenic compounds in peripheral human lymphocytes analysed by cytokinesis-block micronucleus assay. Mutagenesis 2007; 22: 255-61.
17. Yu HS, Liao WT, Chai CY. Arsenic carcinogenesis in the skin. J Biomed Sci 2006; 13: 657-66.
18. Yoshida T, Yamauchi H, Fan SG. Chronic health effects in people exposed to arsenic via the drinking water: dose-response relationships in review. Toxicol Appl Pharmacol 2004; 198: 243-52.
19. U.S. Environmental Protection Agency. Integrated Risk Information System (IRIS). Online. Washington, DC: Office of Research and Development, National Center for Environmental Assessment [updated 2008]. Available from: www.epa.gov/iris, accessed on February 5, 2008.
20. Friberg L, Kjellström T, Elinder CG, Nordberg GF. Cadmium and health: a toxicological and epidemiological appraisal, vol. I, Exposure, dose and metabolism. Boca Raton, FL: CRC Press; 1985.
21. Foulkes EC. Absorption of cadmium. In: Foulkes EC, editor. Handbook of experimental pharmacology, vol. 80. Berlin: Springer-Verlag; 1986. p. 75-100.
22. Sumino K, Hayakawa K, Shibata T, Kitamura S. Heavy metals in normal Japanese tissues. Amounts of 15 heavy metals in 30 subjects. Arch Environ Health 1975; 30: 487-94.
23. Friberg L, Kjellström T, Elinder CG, Nordberg GF. Cadmium and health: a toxicological and epidemiological appraisal, vol. II, Effects and response. Boca Raton, FL: CRC Press; 1986.
24. U.S. Environmental Protection Agency. Integrated Risk Information System (IRIS). IRIS assessment for cadmium (CASRN 7440-43-9). Washington, DC: Office of Research and Development, National Center for Environmental Assessment [updated 1994]. Available from: http://www.epa.gov/ncea/iris/subst/0141.htm, accessed in February 2008.
25. Gill KD, Pal R, Sandhir R, Nath R. Effect of chronic cadmium exposure on lipid composition and peroxidation in liver and kidneys in rats. Med Sci Res 1989; 17: 921-3.
26. Zhu G, Wang H, Shi Y, Weng S, Jin T, Kong Q, et al. Environmental cadmium exposure and forearm bone density. Biometals 2004; 17: 499-503.
27. Jarup L, Alfven T. Low level cadmium exposure, renal and bone effects-the OSCAR study. Biometals 2004; 17: 505-9.
28. Kazantizis G. Cadmium, osteoporosis and calcium metabolism. Toxicol Appl Pharmacol 2004; 198: 243-52.
29. Nation JR, Grover CA, Bratton GR, Salinas JA. Behavioral antagonism between lead and cadmium. Neurotoxicol Teratol 1990; 12: 99-104.
30. Schoeters G, Den HE, Zuurbier M, Naginiene R, van den HP, Stilianakis N, et al. Cadmium and children: exposure and health effects. Acta Paediatr Suppl 2006; 95: 50-4.
31. Akinloye O, Arowojolu AO, Shittu OB, Anetor JI. Cadmium toxicity: a possible cause of male infertility in Nigeria. Reprod Biol 2006; 6: 17-30.
32. International Programme on Chemical Safety. Inorganic lead, Environmental Health Criteria 165. Geneva: World Health Organization, International Programme on Chemical Safety; 1995.
33. U.S. Environmental Protection Agency. Integrative synthesis: multimedia lead exposure, human health effects, and ecosystem effects, Chapter. 8. Report No.: EPA/600/R 5/144aF. Washington, DC: U.S. Environmental Protection Agency; 2006.
34. U.S. Environmental Protection Agency. Recommendations of the technical review workgroup for lead for an interim approach to assessing risks associated with adult exposures to lead in soil. Washington, DC: U.S. Environmental Protection Agency Technical Review Workgroup for Lead; 1996.
35. National Academy of Sciences, National Research Council. Food and nutrition board: recommended dietary allowances, 10th revised edition. Washington, DC: National Academy Press; 1989. p. 205-13, 284.
36. U.S. Environmental Protection Agency. Integrated Risk Information System (IRIS). Toxicological review of zinc and compounds (CASRN 7440-66-6). Washington, DC: U S Environmental Protection Agency [updated 2005]. Available from: http://www.epa.gov/ncea/iris/ toxreviews/0426-tr.pdf, accessed in February 2008.
37. Bush AI, Pettingell WH, Multhaup G, Paradis M, Vonsattel JP, Gusella JF, et al. Rapid induction of Alzheimer A beta amyloid formation by zinc. Science 1994; 265: 1464-7.
38. Kaiser J. Alzheimer's: could there be a zinc link? Science 1994; 265: 1365.
39. Friberg L, Nordberg GF, Vouk VB, Kessler E, editors. Handbook on the toxicology of metals. 2nd ed. Amsterdam: Elsevier; 1986. p. 242, 668, 671.
40. National Research Council. Nutrient requirements of laboratory animals, 4th revised edition. Washington, DC: National Academy Press; 1995. p. 11-102.
41. Bushnell PJ, Levin ED. Effects of zinc deficiency on lead toxicity in rats. Neurobehav Toxicol Teratol 1983; 5: 283-8.
42. U.S. Environmental Protection Agency. Recommendations for and documentation of biological values for risk assessment. Report No.: EPA/600/6-87/008. NTIS PB88-179874. Washington, DC: Prepared by the Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office, Cincinnati, OH for the Office of Solid Waste and Emergency Response; 1988.
43. Agency for Toxic Substances and Diseases Registry. Case-control study to determine risk factors for elevated blood lead levels in children: the Silver Valley Idaho. Report No.: NTIS/PB95-253837. Atlanta, GA: U.S. Department of Health and Human Services; 1995.
44. Storm GL, Fosmire GJ, Bellis ED. Persistence of metals in soil and selected vertebrates in the vicinity of the Palmerton zinc smelters. J Environ Qual 1994; 23: 508-14.
45. Mahaffey KR, Fowler BA. Effects of concurrent administration of lead, cadmium, and arsenic in the rat. Environ Health Perspect 1977; 19: 165-71.
46. Fowler BA, Mahaffey KR. Interactions among lead, cadmium, and arsenic in relation to porphyrin excretion patterns. Environ Health Perspect 1978; 25: 87-90.
47. Mahaffey KR, Capar SG, Gladen BC, Fowler BA. Concurrent exposure to lead, cadmium, and arsenic. Effects on toxicity and tissue metal concentrations in the rat. J Lab Clin Med 1981; 98: 463-81.
48. Thawley DG, Willoughby RA, McSherry BJ, MacLeod GK, MacKay KH, Michell WR. Toxic interactions among Pb, Zn, and Cd with varying levels of dietary Ca and vitamin D: Hematological system. Environ Res 1977; 14: 463-75.
49. Wojcik A, Kubajka J. Experimental study of heavy metal interactions in mice. Ann Univ Mariae Curie Sklodowska (Med) 1990; 45: 21-6.
50. Khadzhieva I, Kuneva T. The interaction between lead, cadmium and essential trace elements (an experimental study). Probl Khig 1992; 17: 199-208.
51. Skoczynska A, Smolik R. The effect of combined exposure to lead and cadmium on serum lipids and lipid peroxides level in rats. Int J Occup Med Environ Health 1994; 7: 263-71.
52. Skoczynska A, Smolik R, Milian A. The effect of combined exposure to lead and cadmium on the concentration of zinc and copper in rat tissues. Int J Occup Med Environ Health 1994; 7: 41-9.
53. Schmolke G, Elsenhans B, Ehtechami C, Forth W. Arsenic-copper interaction in the kidney of the rat. Hum Exp Toxicol 1992; 11: 315-21.
54. az-Barriga F, Llamas E, Mejia JJ, Carrizales L, Santoyo ME, Vega-Vega L, et al. Arsenic-cadmium interaction in rats. Toxicology 1990; 64: 191-203.
55. Yanez L, Carrizales L, Zanatta MT, Mejia JJ, Batres L, az-Barriga F. Arsenic-cadmium interaction in rats: toxic effects in the heart and tissue metal shifts. Toxicology 1991; 67: 227-34.
56. Hochadel JF, Waalkes MP. Sequence of exposure to cadmium and arsenic determines the extent of toxic effects in male Fischer rats. Toxicology 1997; 116: 89-98.
57. Albores A, Koropatnick J, Cherian MG, Zelazowski AJ. Arsenic induces and enhances rat hepatic metallothionein production in vivo. Chem Biol Interact 1992; 85: 127-40.
58. Suzuki CA, Ohta H, Albores A, Koropatnick J, Cherian MG. Induction of metallothionein synthesis by zinc in cadmium pretreated rats. Toxicology 1990; 63: 273-84.
59. Kreppel H, Kolb K, Reichl FX, Fichtl B, Forth W. Pretreatment with low doses of cadmium or zinc decreases lethality in mice acutely poisoned with arsenic. Trace Element Anal Chem Med Biol 1988; 5: 594-600.
60. Kreppel H, Liu J, Liu Y, Reichl FX, Klaassen CD. Zinc-induced arsenite tolerance in mice. Fundam Appl Toxicol 1994; 23: 32-7.
61. Marlowe M, Stellern J, Errera J, Moon C. Main and interaction effects of metal pollutants on visual-motor performance. Arch Environ Health 1985; 40: 221-5.
62. Marlowe M, Cossairt A, Moon C, Errera J, MacNeel A, Peak R, et al. Main and interaction effects of metallic toxins on classroom behavior. J Abnorm Child Psychol 1985; 13: 185-98.
63. Moon C, Marlowe M, Stellern J, Errera J. Main and interaction effects of metallic pollutants on cognitive functioning. J Learn Disabil 1985; 18: 217-21.
64. Mejia JJ, az-Barriga F, Calderon J, Rios C, Jimenez-Capdeville ME. Effects of lead-arsenic combined exposure on central monoaminergic systems. Neurotoxicol Teratol 1997; 19: 489-97.
65. Fairhall LT, Miller JW. A study of the relative toxicity of the molecular components of lead arsenate. Public Health Rep 1941; 56: 1610-25.
66. Engel RR, Hopenhayn-Rich C, Receveur O, Smith AH. Vascular effects of chronic arsenic exposure: a review. Epidemiol Rev 1994; 16: 184-209.
67. Peraza MA, yala-Fierro F, Barber DS, Casarez E, Rael LT. Effects of micronutrients on metal toxicity. Environ Health Perspect 1998; 106 (Suppl 1): 203-16.
68. Engel RR, Receveur O. Arsenic ingestion and internal cancers: a review. Am J Epidemiol 1993; 138: 896-7.
69. Lin SM, Yang MH. Arsenic, selenium, and zinc in patients with Blackfoot disease. Biol Trace Elem Res 1988; 15: 213-21.
70. Pan TC, Lin TH, Tseng CL, Yang MH, Huang CW. Trace elements in hair of Blackfoot disease. Biol Trace Elem Res 1993; 39: 117-28.
71. Wang CT, Huang CW, Chou SS, Lin DT, Liau SR, Wang RT. Studies on the concentration of arsenic, selenium, copper, zinc and iron in the blood of blackfoot disease patients in different clinical stages. Eur J Clin Chem Clin Biochem 1993; 31: 759-63.
72. Maitani T, Saito N, Abe M, Uchiyama S, Saito Y. Chemical form-dependent induction of hepatic zinc-thionein by arsenic administration and effect of co-administered selenium in mice. Toxicol Lett 1987; 39: 63-70.
73. Kreppel H, Bauman JW, Liu J, McKim JM, Jr, Klaassen CD. Induction of metallothionein by arsenicals in mice. Fundam Appl Toxicol 1993; 20: 184-9.
74. Buchet JP, Lauwerys R. Study of inorganic arsenic methylation by rat liver in vitro: relevance for the interpretation of observations in man. Arch Toxicol 1985; 57: 125-9.
75. Hirata M, Tanaka A, Hisanaga A, Ishinishi N. Effects of glutathione depletion on the acute nephrotoxic potential of arsenite and on arsenic metabolism in hamsters. Toxicol Appl Pharmacol 1990; 106: 469-81.
76. Xu B, Chia SE, Ong CN. Concentrations of cadmium, lead, selenium, and zinc in human blood and seminal plasma. Biol Trace Elem Res 1994; 40: 49-57.
77. Foulkes EC. Intestinal absorption of heavy metals. In: Csaky TZ, editor. Handbook of experimental pharmacology, vol.70/I. Pharmacology of intestinal permeation. Berlin: Springer-Verlag; 1984. p. 543-65.
78. Buchet JP, Roels H, Bernard A, Lauwerys R. Assessment of renal function of workers simultaneously exposed to inorganic lead and cadmium. J Occup Med 1981; 23: 348-52.
79. Roels HA, Buchet JP, Bernard A, Hubermont G, Lauwerys RR, Masson P. Investigations of factors influencing exposure and response to lead, mercury, and cadmium in man and in animals. Environ Health Perspect 1978; 25: 91-6.
80. Exon JH, Koller LD, Kerkvliet NI. Lead-cadmium interaction: effects on viral-induced mortality and tissue residues in mice. Arch Environ Health 1979; 34: 469-75.
81. Nation JR, Frye GD, Von SJ, Bratton GR. Effects of combined lead and cadmium exposure: changes in schedule-controlled responding and in dopamine, serotonin, and their metabolites. Behav Neurosci 1989; 103: 1108-14.
82. Kopp SJ, Glonek T, Erlanger M, Perry EF, Barany M, Perry HM, Jr. Altered metabolism and function of rat heart following chronic low level cadmium/ lead feeding. J Mol Cell Cardiol 1980; 12: 1407-25.
83. Kopp SJ, Barany M, Erlanger M, Perry EF, Perry HM, Jr. The influence of chronic low-level cadmium and/or lead feeding on myocardial contractility related to phosphorylation of cardiac myofibrillar proteins. Toxicol Appl Pharmacol 1980; 54: 48-56.
84. Perry HM Jr, Erlanger MW. Pressor effects of chronically feeding cadmium and lead together. Trace Subst Environ Health 1978; 12: 268-75.
85. Perry HM Jr, Erlanger MW, Perry EF. Effect of a second metal on cadmium-induced hypertension. Arch Environ Health 1983; 38: 80-5.
86. Bartolin R, Bouvenot G, Arnaud C, Turzanski JM, Gadroy P, Rey PA. Blood cadmium and plasma zinc in hypertensive patients. Apropos of 76 cases. Rev Med Interne 1985; 6: 280-4.
87. Kraus G, Schaller KH, Winter L. The modification of different element levels in human blood by occupational cadmium exposure. Zentralbl Bakteriol Mikrobiol Hyg(B) 1988; 186: 95-107.
88. Bebe FN, Panemangalore M. Modulation of tissue trace metal concentrations in weanling rats fed different levels of zinc and exposed to oral lead and cadmium. Nutr Res 1996; 16: 1369-80.
89. Groten JP, Sinkeldam EJ, Muys T, Luten JB, van Bladeren PJ. Interaction of dietary Ca, P, Mg, Mn, Cu, Fe, Zn and Se with the accumulation and oral toxicity of cadmium in rats. Food Chem Toxicol 1991; 29: 249-58.
90. Lal JB. The effects of low and high levels of dietary zinc on pathology in rats exposed to cadmium. PhD Dissertation. Cincinnati, OH: University of Cincinnati; 1976.
91. Petering HG, Choudhury H, Stemmer KL. Some effects of oral ingestion of cadmium on zinc, copper, and iron metabolism. Environ Health Perspect 1979; 28: 97-106.
92. Sullivan MF, Hardy JT, Miller BM, Buschbom RL, Siewicki TC. Absorption and distribution of cadmium in mice fed diets containing either inorganic or oyster-incorporated cadmium. Toxicol Appl Pharmacol 1984; 72: 210-7.
93. Waalkes MP. Effect of dietary zinc deficiency on the accumulation of cadmium and metallothionein in selected tissues of the rat. J Toxicol Environ Health 1986; 18: 301-13.
94. Ohta H, Cherian MG. Gastrointestinal absorption of cadmium and metallothionein. Toxicol Appl Pharmacol 1991; 107: 63-72.
95. Tanaka M, Yanagi M, Shirota K, Une Y, Nomura Y, Masaoka T, et al. Effect of cadmium in the zinc deficient rat. Vet Hum Toxicol 1995; 37: 203-8.
96. Volkova NA, Garibian GM, Karpliuk IA. Effect of zinc in diet on course of chronic cadmium intoxication in experiment. Vopr Pitan 1994; 5: 21-3.
97. Banis RJ, Pond WG, Walker EF Jr, O'Connor JR. Dietary cadmium, iron, and zinc interactions in the growing rat. Proc Soc Exp Biol Med 1969; 130: 802-6.
98. Bunn CR, Matrone G. In vivo interactions of cadmium, copper, zinc and iron in the mouse and rat. J Nutr 1966; 90: 395-9.
99. Parzyck DC, Shaw SM, Kessler WV, Vetter RJ, Van S, Mayes RA. Fetal effects of cadmium in pregnant rats on normal and zinc deficient diets. Bull Environ Contam Toxicol 1978; 19: 206-14.
100. Ferm VH, Carpenter SJ. Teratogenic effect of cadmium and its inhibition by zinc. Nature 1967; 216: 1123.
101. Hartsfield JK Jr, Lee M, Morel JG, Hilbelink DR. Statistical analysis of the effect of cadmium and zinc on hamster teratogenesis. Biochem Med Metab Biol 1992; 48: 159-73.
102. Johnson NE, Tenuta K. Diets and lead blood levels of children who practice pica. Environ Res 1979; 18: 369-76.
103. Markowitz ME, Rosen JF. Zinc (Zn) and copper (Cu) metabolism in CaNa2EDTA-treated children with plumbism. Pediatr Res 1981; 15: 635-49.
104. Kies C, Ip SW. Lead bioavailability to humans from diets containing constant amounts of lead: impact of supplemental copper, zinc and iron. Trace Subst Environ Health 1990; 14: 178-84.
105. Lauwerys R, Roels H, Buchet JP, Bernard AA, Verhoeven L, Konings J. The influence of orally-administered vitamin C or zinc on the absorption of and the biological response to lead. J Occup Med 1983; 25: 668-78.
106. Papaionannou R, Sohler A, Pfeiffer CC. Reduction of blood lead levels in battery workers by zinc and vitamin C. J Orthomol Psychiatry 1978; 7: 94-106.
107. Sohler A, Kruesi M, Pfeiffer CC. Blood lead levels in psychiatric outpatients reduced by zinc and vitamin C. J Orthomol Psychiatry 1977; 6: 272-6.
108. Cerklewski FL, Forbes RM. Influence of dietary zinc on lead toxicity in the rat. J Nutr 1976; 106: 689-96.
109. Cerklewski FL. Influence of dietary zinc on lead toxicity during gestation and lactation in the female rat. J Nutr 1979; 109: 1703-9.
110. El-Gazzar RM, Finelli VN, Boiano J, Petering HG. Influence of dietary zinc on lead toxicity in rats. Toxicol Lett 1978; 1: 227-34.
111. Flora SJ, Jain VK, Behari JR, Tandon SK. Protective role of trace metals in lead intoxication. Toxicol Lett 1982; 13: 51-6.
112. Flora SJ, Kumar D, Das GS. Interaction of zinc, methionine or their combination with lead at gastrointestinal or post-absorptive level in rats. Pharmacol Toxicol 1991; 68: 3-7.
113. Hietanen E, Aitio A, Koivusaari U, Kilpio J, Nevalainen T, Narhi M, et al. Tissue concentrations and interaction of zinc with lead toxicity in rabbits. Toxicology 1982; 25: 113-27.
114. Hsu FS, Krook L, Pond WG, Duncan JR. Interactions of dietary calcium with toxic levels of lead and zinc in pigs. J Nutr 1975; 105: 112-8.
115. Chisolm JJ, Jr. Dose-effect relationships for lead in young children: evidence in children for interactions among lead, zinc, and iron. In: Lynam DR, Piantanida LGF, Cole JF, editors. Environmental lead: proceedings of the second International Symposium on Environmental Lead Research. New York: Academic Press; 1981. p. 1-7.
116. Thomasino JA, Zuroweste E, Brooks SM, Petering HG, Lerner SI, Finelli VN. Lead, zinc, and erythrocyte delta-aminolevulinic acid dehydratase: relationships in lead toxicity. Arch Environ Health 1977; 32: 244-7.
117. Mauras Y, Allain P. Inhibition of delta-aminolevulinic acid dehydratase in human red blood cells by lead and activation by zinc or cysteine. Enzyme 1979; 24: 181-7.
118. Davis JR, Avram MJ. A comparison of the stimulatory effects of cadmium and zinc on normal and lead-inhibited human erythrocytic delta-aminolevulinic acid dehydratase activity in vitro. Toxicol Appl Pharmacol 1978; 44: 181-90.
119. Flora SJ, Bhattacharya R, Sachan SR. Dose-dependent effects of zinc supplementation during chelation of lead in rats. Pharmacol Toxicol 1994; 74: 330-3.
120. Thawley DG, Pratt SE, Selby LA. Antagonistic effect of zinc on increased urine delta-aminolevulinic acid excretion in lead-intoxicated rats. Environ Res 1978; 15: 218-26.
121. Cerklewski FL. Postabsorptive effect of increased dietary zinc on toxicity and removal of tissue lead in rats. J Nutr 1984; 114: 550-4.
122. Goering PL, Fowler BA. Metal constitution of metallothionein influences inhibition of delta-aminolaevulinic acid dehydratase (porphobilinogen synthase) by lead. Biochem J 1987; 245: 339-45.
123. Haeger-Aronsen B, Schutz A. Antagonistic effect in vivo of zinc on inhibition of delta-aminolevulinic acid dehydratase by lead. Arch Environ Health 1976; 31: 215-20.
124. Finelli VN, Klauder DS, Karaffa MA, Petering HG. Interaction of zinc and lead on delta-aminolevulinate dehydratase. Biochem Biophys Res Commun 1975; 65: 303-12.
125. Liu J, Kershaw WC, Klaassen CD. The protective effect of metallothionein on the toxicity of various metals in rat primary hepatocyte culture. Toxicol Appl Pharmacol 1991; 107: 27-34.
126. Church HJ, Day JP, Braithwaite RA, Brown SS. Binding of lead to a metallothionein-like protein in human erythrocytes. J Inorg Biochem 1993; 49: 55-68.
127. Aschner M, Cherian MG, Klaassen CD, Palmiter RD, Erickson JC, Bush AI. Metallothioneins in brain-the role in physiology and pathology. Toxicol Appl Pharmacol 1997; 142: 229-42.
128. Araki S, Murata K, Yokoyama K, Uchida E. Auditory event-related potential (P300) in relation to peripheral nerve conduction in workers exposed to lead, zinc, and copper: effects of lead on cognitive function and central nervous system. Am J Ind Med 1992; 21: 539-47.
129. Araki S, Murata K, Uchida E, Aono H, Ozawa H. Radial and median nerve conduction velocities in workers exposed to lead, copper, and zinc: a follow-up study for 2 years. Environ Res 1993; 61: 308-16.
130. Murata K, Araki S. Autonomic nervous system dysfunction in workers exposed to lead, zinc, and copper in relation to peripheral nerve conduction: a study of R-R interval variability. Am J Ind Med 1991; 20: 663-71.
131. Guilarte TR, Miceli RC, Jett DA. Biochemical evidence of an interaction of lead at the zinc allosteric sites of the NMDA receptor complex: effects of neuronal development. Neurotoxicology 1995; 16: 63-71.
132. Vassilev PP, Venkova K, Pencheva N, Radomirov R, Staneva- Stoytcheva D. Changes in the contractile responses to carbachol and in the inhibitory effects of verapamil and nitrendipine on isolated smooth muscle preparations from rats subchronically exposed to Pb2+ and Zn2+. Pharmacol Toxicol 1994; 75: 129-35.
133. Goering PL. Lead-protein interactions as a basis for lead toxicity. Neurotoxicology 1993; 14: 45-60.
134. Monteiro HP, Bechara EJ, Abdalla DS. Free radicals involvement in neurological porphyrias and lead poisoning. Mol Cell Biochem 1991; 103: 73-83.
135. Yoshikawa H, Ohta H. Interaction of metals and metallothionein. In: Foulkes EC, editor. Biological roles of metallothionein. Amsterdam: Elsevier; 1982. p. 11-23.
136. Willoughby RA, Macdonald E, McSherry BJ, Brown G. Lead and zinc poisoning and the interaction between Pb and Zn poisoning in the foal. Can J Comp Med 1972; 36: 348-59.
137. Kroes R, van Logten MJ, Berkvens JM, de VT, van Esch GJ. Study on the carcinogenicity of lead arsenate and sodium arsenate and on the possible synergistic effect of diethylnitrosamine. Food Cosmet Toxicol 1974; 12: 671-9.
138. Hertzberg RC, Rice G, Teuschler L. Methods for health risk assessment of combustion mixtures. In: Roberts SM, Bean JA, Teaf CM, editors. Hazardous waste incineration: evaluating the human health and environmental risks. Boca Raton, FL: CRC Press; 1998.
139. U.S. Environmental Protection Agency. Workshop report: the risk assessment of mixtures of disinfection byproducts (DBPs) in drinking water, May 19-20, 1998. Report No.: NCEA-C-0459. Cincinnati, OH: U.S. Environmental Assessment Agency, National Center for Environmental Assessment; 1998. p. 69-75.
140. Mumtaz MM, Poirier KA, Colman JT. Risk assessment for chemical mixtures: fine-tuning the hazard index approach. J Clean Technol Environ Toxicol Occup Med 1997; 6: 189-204.